Literature DB >> 20617879

The role of hypoxia-inducible factor-1α, aquaporin-4, and matrix metalloproteinase-9 in blood-brain barrier disruption and brain edema after traumatic brain injury.

Tetsuhiro Higashida1, Christian W Kreipke, José A Rafols, Changya Peng, Steven Schafer, Patrick Schafer, Jamie Y Ding, David Dornbos, Xiaohua Li, Murali Guthikonda, Noreen F Rossi, Yuchuan Ding.   

Abstract

OBJECT: The present study investigated the role of hypoxia-inducible factor-1α (HIF-1α), aquaporin-4 (AQP-4), and matrix metalloproteinase-9 (MMP-9) in blood-brain barrier (BBB) permeability alterations and brain edema formation in a rodent traumatic brain injury (TBI) model.
METHODS: The brains of adult male Sprague-Dawley rats (400-425 g) were injured using the Marmarou closed-head force impact model. Anti-AQP-4 antibody, minocycline (an inhibitor of MMP-9), or 2-methoxyestradiol (2ME2, an inhibitor of HIF-1α), was administered intravenously 30 minutes after injury. The rats were killed 24 hours after injury and their brains were examined for protein expression, BBB permeability, and brain edema. Expression of HIF-1α, AQP-4, and MMP-9 as well as expression of the vascular basal lamina protein (laminin) and tight junction proteins (zona occludens-1 and occludin) was determined by Western blotting. Blood-brain barrier disruption was assessed by FITC-dextran extravasation, and brain edema was measured by the brain water content.
RESULTS: Significant (p < 0.05) edema and BBB extravasations were observed following TBI induction. Compared with sham-operated controls, the injured animals were found to have significantly (p < 0.05) enhanced expression of HIF-1α, AQP-4, and MMP-9, in addition to reduced amounts (p < 0.05) of laminin and tight junction proteins. Edema was significantly (p < 0.01) decreased after inhibition of AQP-4, MMP-9, or HIF-1α. While BBB permeability was significantly (p < 0.01) ameliorated after inhibition of either HIF-1α or MMP-9, it was not affected following inhibition of AQP-4. Inhibition of MMP reversed the loss of laminin (p < 0.01). Finally, while inhibition of HIF-1α significantly (p < 0.05) suppressed the expression of AQP-4 and MMP-9, such inhibition significantly (p < 0.05) increased the expression of laminin and tight junction proteins.
CONCLUSIONS: The data support the notion that HIF-1α plays a role in brain edema formation and BBB disruption via a molecular pathway cascade involving AQP-4 and MMP-9. Pharmacological blockade of this pathway in patients with TBI may provide a novel therapeutic strategy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20617879     DOI: 10.3171/2010.6.JNS10207

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  116 in total

1.  Ghrelin prevents disruption of the blood-brain barrier after traumatic brain injury.

Authors:  Nicole E Lopez; Michael J Krzyzaniak; Chelsea Blow; James Putnam; Yan Ortiz-Pomales; Ann-Marie Hageny; Brian Eliceiri; Raul Coimbra; Vishal Bansal
Journal:  J Neurotrauma       Date:  2011-10-26       Impact factor: 5.269

Review 2.  Neuroinflammation: a common pathway in CNS diseases as mediated at the blood-brain barrier.

Authors:  Michelle A Erickson; Kenji Dohi; William A Banks
Journal:  Neuroimmunomodulation       Date:  2012-01-11       Impact factor: 2.492

3.  Delayed increase of astrocytic aquaporin 4 after juvenile traumatic brain injury: possible role in edema resolution?

Authors:  A M Fukuda; V Pop; D Spagnoli; S Ashwal; A Obenaus; J Badaut
Journal:  Neuroscience       Date:  2012-06-21       Impact factor: 3.590

4.  bFGF Protects Against Blood-Brain Barrier Damage Through Junction Protein Regulation via PI3K-Akt-Rac1 Pathway Following Traumatic Brain Injury.

Authors:  Zhou-Guang Wang; Yi Cheng; Xi-Chong Yu; Li-Bing Ye; Qing-Hai Xia; Noah R Johnson; Xiaojie Wei; Da-Qing Chen; Guodong Cao; Xiao-Bing Fu; Xiao-Kun Li; Hong-Yu Zhang; Jian Xiao
Journal:  Mol Neurobiol       Date:  2015-12-21       Impact factor: 5.590

Review 5.  Bridge between neuroimmunity and traumatic brain injury.

Authors:  Matthew L Kelso; Howard E Gendelman
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

6.  Altered levels of plasma neuron-derived exosomes and their cargo proteins characterize acute and chronic mild traumatic brain injury.

Authors:  Edward J Goetzl; Fanny M Elahi; Maja Mustapic; Dimitrios Kapogiannis; Moira Pryhoda; Anah Gilmore; Kimberly A Gorgens; Bradley Davidson; Anne-Charlotte Granholm; Aurélie Ledreux
Journal:  FASEB J       Date:  2019-01-03       Impact factor: 5.191

Review 7.  Disruption of ion homeostasis in the neurogliovascular unit underlies the pathogenesis of ischemic cerebral edema.

Authors:  Arjun Khanna; Kristopher T Kahle; Brian P Walcott; Volodymyr Gerzanich; J Marc Simard
Journal:  Transl Stroke Res       Date:  2013-11-22       Impact factor: 6.829

Review 8.  Matrix metalloproteinases as therapeutic targets for stroke.

Authors:  Yi Yang; Gary A Rosenberg
Journal:  Brain Res       Date:  2015-04-25       Impact factor: 3.252

9.  Bazedoxifene protects cerebral autoregulation after traumatic brain injury and attenuates impairments in blood-brain barrier damage: involvement of anti-inflammatory pathways by blocking MAPK signaling.

Authors:  Yu-Long Lan; Xun Wang; Yu-Jie Zou; Jin-Shan Xing; Jia-Cheng Lou; Shuang Zou; Bin-Bin Ma; Yan Ding; Bo Zhang
Journal:  Inflamm Res       Date:  2019-01-31       Impact factor: 4.575

Review 10.  Early to Long-Term Alterations of CNS Barriers After Traumatic Brain Injury: Considerations for Drug Development.

Authors:  Beatriz Rodriguez-Grande; Aleksandra Ichkova; Sighild Lemarchant; Jerome Badaut
Journal:  AAPS J       Date:  2017-09-13       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.